Abstract
Summary
According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size 2024-2029
2.1.2 Nucleic Acid Drugs Market Size CAGR by Region
2.2 Nucleic Acid Drugs Segment by Type
2.2.1 Antisense Nucleic Acid Drugs
2.2.2 siRNA Drugs
2.2.3 saRNA Drugs
2.2.4 miRNA Drugs
2.2.5 mRNA Drugs
2.2.6 other
2.3 Nucleic Acid Drugs Market Size by Type
2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Nucleic Acid Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid Drugs Market Size by Application
2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2024-2029)
3 Nucleic Acid Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid Drugs
3.2 Key Players Nucleic Acid Drugs Product Offered
3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Nucleic Acid Drugs by Regions
4.1 Nucleic Acid Drugs Market Size by Regions (2024-2029)
4.2 United States Nucleic Acid Drugs Market Size Growth (2024-2029)
4.3 China Nucleic Acid Drugs Market Size Growth (2024-2029)
4.4 Europe Nucleic Acid Drugs Market Size Growth (2024-2029)
4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2024-2029)
5 United States
5.1 United States Nucleic Acid Drugs Market Size by Type (2024-2029)
5.2 United States Nucleic Acid Drugs Market Size by Application (2024-2029)
6 Europe
6.1 Europe Nucleic Acid Drugs Market Size by Type (2024-2029)
6.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2029)
7 China
7.1 China Nucleic Acid Drugs Market Size by Type (2024-2029)
7.2 China Nucleic Acid Drugs Market Size by Application (2024-2029)
8 Rest of World
8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2024-2029)
8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Nucleic Acid Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics News
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals News
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Nucleic Acid Drugs Product Offered
11.3.3 Alnylam Nucleic Acid Drugs Market Size (2023 VS 2029)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam News
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics Company Details
11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered
11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.4.4 Mina Therapeutics Main Business Overview
11.4.5 Mina Therapeutics News
11.5 BioNTech
11.5.1 BioNTech Company Details
11.5.2 BioNTech Nucleic Acid Drugs Product Offered
11.5.3 BioNTech Nucleic Acid Drugs Market Size (2023 VS 2029)
11.5.4 BioNTech Main Business Overview
11.5.5 BioNTech News
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals Company Details
11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered
11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029)
11.6.4 NeXstar Pharmaceuticals Main Business Overview
11.6.5 NeXstar Pharmaceuticals News
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2023 VS 2029)
11.7.4 Nippon Shinyaku Main Business Overview
11.7.5 Nippon Shinyaku News
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics Company Details
11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.8.4 Moderna Therapeutics Main Business Overview
11.8.5 Moderna Therapeutics News
11.9 CureVac
11.9.1 CureVac Company Details
11.9.2 CureVac Nucleic Acid Drugs Product Offered
11.9.3 CureVac Nucleic Acid Drugs Market Size (2023 VS 2029)
11.9.4 CureVac Main Business Overview
11.9.5 CureVac News
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics Company Details
11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.10.4 Regulus Therapeutics Main Business Overview
11.10.5 Regulus Therapeutics News
11.11 Miragen Therapeutics
12 Research Findings and Conclusion